ProVerum (ProVerum Medical / ProVerum Ltd.)
Irish MedTech company developing the ProVee system — a nitinol, low-profile, stent-like expander implant with a flexible steerable delivery and integrated imaging for a minimally invasive, reversible treatment of benign prostatic hyperplasia (BPH). Completed an international clinical program including a randomized sham-controlled pivotal (ProVIDE) study; product currently an investigational device with commercial availability pending.
Finanzierungsrunden
1
Gesamtvolumen
€68.6 Mio.
Letzte Runde
Series B
Investoren
7
Finanzierung nach Stage
Finanzierungsrunden
| Stage | Betrag | Investoren | Datum |
|---|---|---|---|
| Series B | €68.6 Mio. | 27. Aug. 2025 |
